Growel Formulations Private Limited

Growel Formulations Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG1993PTC015700 Incorporated 29 April 1993 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2024
₹190.99 Cr
▼ 30% YoY
Net profit · FY 2024
₹30.31 Cr
Net margin 15.9%
EBITDA · FY 2024
₹39.78 Cr
EBITDA margin 20.8%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹7.21 Cr
Issued & subscribed
Open charges
₹45.96 Cr
Satisfied ₹1.75 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
104
Provident fund records

About Growel Formulations Private Limited

Data last updated:

Growel Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 29 April 1993 and has been in existence for over 33 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1993PTC015700. Its GSTIN is 36AAACG7485L1Z3 (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹7.21 Cr. It is led by directors including Vedadri Narasimha Sesha Chary Mudumbi (Whole-Time Director) and Ranga Kirtana Mudumbi.

Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Survey No.64 – 67 Chengicherla Village Road Rangareddy District, Hyderabad, Telangana, India – 500039.

As per the financials filed for FY 2024, the company reported a revenue of ₹190.99 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹30.31 Cr (net margin 15.9%) and EBITDA of ₹39.78 Cr (EBITDA margin 20.8%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 2% over five years.

The company has about 104 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Growel Formulations. As per MCA filings, the company has open charges of ₹45.96 Cr and satisfied charges of ₹1.75 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it. The company has 4 deals on record (4 secondary share transfers); the latest was in September 2020. The company has 11 MSME Form 1 returns on record between 2019 and 2023, listing 600 overdue payments to 15 micro and small suppliers.

Growel Formulations Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0011438). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website growelformulations.com.

Company details

CIN U24239TG1993PTC015700
Registration Number 015700
Incorporation Date 29 April 1993
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0011438

CIN history

Growel Formulations has one previous CIN (Corporate Identification Number): U24239AP1993PTC015700. The current CIN is U24239TG1993PTC015700, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG1993PTC015700Current
U24239AP1993PTC015700Previous
Key People
Vedadri Narasimha Sesha Chary Mudumbi Whole-Time Director Ranga Kirtana Mudumbi Director Padma Preeti Mudumbi Director

Recognitions & Rankings of Growel Formulations

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-TS-20-0011438

Contact details

Growel Formulations Private Limited's registered office is in Hyderabad, Telangana. Its website is growelformulations.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    growelformulations.com
  • Social Media
  • Registered Address
    Survey No.64 – 67 Chengicherla Village Road Rangareddy District, Hyderabad, Telangana, India – 500039
  • Industry
    Pharma, Animal Pharmaceuticals & Healthcare

To see the full contact details of Growel Formulations Private Limited, buy the company report.

Comprehensive company report
Growel Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Growel Formulations operates one associated brand: Growel Formulations. Each brand links to its own profile.

BrandDescriptionWebsite
Growel Formulations
Aquaculture healthcare products are manufactured and supplied for aquatic species.growelformulations.com

Business activity

The main business activity of Growel Formulations is agriculture, forestry, fishing. In detail, this covers fishing and aquaculture and support activities to agriculture and other activities including hunting. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
AAgriculture, forestry, fishingA3Fishing and aquaculture
AAgriculture, forestry, fishingA4Support activities to agriculture and Other Activities including hunting

To see the full business activity and turnover split of Growel Formulations Private Limited, buy the company report.

Financials of Growel Formulations Private Limited

FY 2024 filings available

Growel Formulations Private Limited reported revenue of ₹190.99 Cr (down 30% YoY) for FY 2024.

Revenue · FY 2024
₹190.99 Cr ▼ 30%
Net profit · FY 2024
₹30.31 Cr margin 15.9%
EBITDA · FY 2024
₹39.78 Cr margin 20.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 30%
3 years · compounded
▲ 11%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 17%
3 years · compounded
▼ 4%
5 years · compounded
▼ 1%

Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 30% fall in the latest year. EBITDA fell 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹39.78 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹30.31 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin20.8%
Net Profit Margin15.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Growel Formulations Private Limited, buy the company report.

Board of directors of Growel Formulations Private Limited

Growel Formulations has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ranga Kirtana Mudumbi
Also directs: Nayati Malls and Building Services LLP, Million Dreams Creations LLP
Director24 Aug 20179 Years 2 MonthsCurrent
Padma Preeti Mudumbi
Also directs: Nayati Malls and Building Services LLP, Vijaya Saraaga Productions LLP, Spark Elegance LLP
Director24 Aug 20179 Years 2 MonthsCurrent
Vedadri Narasimha Sesha Chary Mudumbi
Also directs: Nayati Malls and Building Services LLP, Growel Feeds Private Limited, Growel Life Sciences Private Limited and 3 more
Whole-Time Director28 Dec 200124 Years 10 MonthsCurrent
View all directors

Auditor

Growel Formulations Private Limited is audited by Praturi & Sriram for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Praturi & SriramFY 2023002739S

Shareholding

The shareholding of Growel Formulations Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Growel Formulations Private Limited, buy the company report.

Charges & borrowings

Open charges
₹45.96 Cr
Satisfied charges
₹1.75 Cr
Breakdown by lending institutions
State Bank of India₹44.06 Cr
Axis Bank Limited₹1.91 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Jun 2024100941542State Bank of India₹3 CrOpen
05 Jul 2022100604892State Bank of India₹27.75 LakhOpen
01 Jul 2020100413119Axis Bank Limited₹72.5 LakhOpen
05 Jul 2019100322204Axis Bank Limited₹1.18 CrOpen
04 Dec 199590123832State Bank of India₹40.78 CrOpen

To see the full charge records of Growel Formulations Private Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Growel Formulations Private Limited has 4 deals on record (4 secondary share transfers); the latest was in September 2020.

Total deals
4
Secondary share transfers
4

Deals on record (4 of 4)

WhenDealAmountParties
Sep 2020Secondary share transferUndisclosedBuyer: 3 individuals
Seller: an individual
Sep 2018Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals
Jul 2017Secondary share transferUndisclosedBuyer: 3 individuals
Seller: an individual
Mar 2017Secondary share transferUndisclosedBuyer: 4 individuals
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Growel Formulations Private Limited was last rated by Crisil on 12 Mar 2020.

Rating agencyRated onRating
Crisil12 Mar 2020

To see the full credit ratings and regulatory alerts of Growel Formulations Private Limited, buy the company report.

MSME payment delays

Growel Formulations Private Limited has 11 MSME Form 1 returns on record between 2019 and 2023, listing 600 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 15)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
Calcutta Plastic Industries LLP
an individual supplier
an individual supplier

To see the full MSME payment records of Growel Formulations Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Growel Formulations has 2 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

2
Associated companies

Employees & EPFO

Growel Formulations Private Limited has a workforce of 104 employees on its EPFO records as of Sep 25, 2025, across 1 active EPFO establishment.

Employee count
104
Active EPFO establishments
1

GST

Growel Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAACG7485L1Z3TelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Growel Formulations Private Limited, buy the company report.

Recent activity

Growel Formulations Private Limited has 7 board changes on record since 2001: 3 appointments and 4 cessations. The latest: Vijaya Lakshmi Mudumbi ceased to be Whole-Time Director on 19 Dec 2019.

AGM
Growel Formulations Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 3.00 Cr with Charge ID 100941542 was registered on 27 Jun 2024.
Filing
Growel Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with State Bank Of India of Rs. 40.78 Cr registered on 04 Dec 1995 with Charge ID 90123832 was modified on 20 Mar 2023.
Charges
A charge with State Bank Of India amounted to Rs. 0.28 Cr with Charge ID 100604892 was registered on 05 Jul 2022.
Charges
A charge registered on 24 Feb 2001 via Charge ID 90122948 with State Bank Of India was fully satisfied on 07 May 2022.
Charges
A charge registered on 01 Jan 1994 via Charge ID 90123710 with State Bank Of India was fully satisfied on 07 May 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.73 Cr with Charge ID 100413119 was registered on 01 Jul 2020.
Ceased
Vijaya Lakshmi Mudumbi ceased to be Whole-Time Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.18 Cr with Charge ID 100322204 was registered on 05 Jul 2019.
Ceased
Padma Preeti Mudumbi ceased to be Additional Director.
Ceased
Ranga Kirtana Mudumbi ceased to be Additional Director.

9 earlier events are in the company report.

News

Frequently asked questions

Growel Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 29 April 1993 (33+ years old) and is registered under CIN U24239TG1993PTC015700.

Growel Formulations has 3 current directors:

The latest financial statements of Growel Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Growel Formulations is 36AAACG7485L1Z3, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Growel Formulations is U24239TG1993PTC015700. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Growel Formulations has 5 court cases on record: 3 filed by the company and 2 filed against it. Most are in the district courts.

Growel Formulations was incorporated on 29 April 1993, making it 33+ years old. It is registered with the Registrar of Companies, Hyderabad.

Growel Formulations has 4 deals on record (4 secondary share transfers); the latest was in September 2020.

Vijaya Lakshmi Mudumbi ceased to be Whole-Time Director on 19 Dec 2019. Padma Preeti Mudumbi ceased to be Additional Director on 16 Sep 2017. Ranga Kirtana Mudumbi ceased to be Additional Director on 16 Sep 2017. Growel Formulations has 7 board changes on record in total.

Yes, Growel Formulations is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-20-0011438).

Growel Formulations has 11 MSME Form 1 returns on record between 2019 and 2023, listing 600 overdue payments to 15 micro and small suppliers. The latest return was filed on 29 Aug 2023.